Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Hruban RH, Shiu MH, Senie RT, Woodruff JM
Evidencebased medications like GLP1 receptor agonists and GLP1/GIP agonists have transformed obesity care, but high prices and limited access can put them out of reach for many people in lowincome communities
Cell Therapy Application in Ischemic Stroke Available Platforms with Metabolic Relevance Mesenchymal stromal cells (MSCs) are the most extensively investigated cellular platform for ischemic stroke therapeutics [19, 21, 23, 24]
B.GodoyM
US$ 29.69
US$ 21.60
US$ 21.79
US$ 26.73
US$ 26.56
US$ 26.00
US$ 26.30
US$ 26.15
US$ 23.62
US$ 25.01
